Glaucoma--2: treatment.
Khaw
P T
PT
Moorfields Eye Hospital, London. p.khaw@ucl.ac.uk
Shah
P
P
Elkington
A R
AR
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D004322:Drainage / Q000379:methods; D005901:Glaucoma / Q000628:therapy*; D006801:Humans; D032801:Iridectomy / Q000379:methods; D053685:Laser Therapy / Q000379:methods; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D018696:Neuroprotective Agents; D010277:Parasympathomimetics; D011453:Prostaglandins